LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 41.11 | 27.76 | 983 | 3331 | 0.2951 | 0.6760 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 41.11 | 27.76 | 996 | 3331 | 0.2990 | 0.6792 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 41.11 | 27.76 | 990 | 3331 | 0.2972 | 0.6778 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 41.11 | 27.76 | 1005 | 3331 | 0.3017 | 0.6814 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 42.81 | 27.76 | 937 | 3596 | 0.2606 | 0.6512 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 42.81 | 27.76 | 948 | 3596 | 0.2636 | 0.6539 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 42.81 | 27.76 | 1072 | 3596 | 0.2981 | 0.6832 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 42.81 | 27.76 | 1090 | 3596 | 0.3031 | 0.6872 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 44.52 | 27.76 | 920 | 3884 | 0.2369 | 0.6341 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 44.52 | 27.76 | 927 | 3884 | 0.2387 | 0.6359 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 44.52 | 27.76 | 1011 | 3884 | 0.2603 | 0.6559 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 44.52 | 27.76 | 1028 | 3884 | 0.2647 | 0.6598 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 46.22 | 27.76 | 988 | 4125 | 0.2395 | 0.6406 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 46.22 | 27.76 | 1000 | 4125 | 0.2424 | 0.6434 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 46.22 | 27.76 | 972 | 4125 | 0.2356 | 0.6369 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 46.22 | 27.76 | 983 | 4125 | 0.2383 | 0.6395 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 47.93 | 27.76 | 947 | 4421 | 0.2142 | 0.6201 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 47.93 | 27.76 | 961 | 4421 | 0.2174 | 0.6234 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 47.93 | 27.76 | 1089 | 4421 | 0.2463 | 0.6514 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 47.93 | 27.76 | 1105 | 4421 | 0.2499 | 0.6547 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 49.63 | 27.76 | 945 | 4818 | 0.1961 | 0.6067 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 49.63 | 27.76 | 959 | 4818 | 0.1990 | 0.6099 | MN20160318_Q01 | D06 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 49.63 | 27.76 | 1029 | 4818 | 0.2136 | 0.6252 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 49.63 | 27.76 | 1043 | 4818 | 0.2165 | 0.6282 | MN20160318_Q01 | H10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 51.33 | 27.76 | 961 | 5117 | 0.1878 | 0.6015 | MN20160318_Q01 | D06 |